Showing of 7 results
Phase II clinical trial of promising approach soon to begin at UH Seidman and second site at the NIH Clinical Center - Innovations in Cancer | Winter 2021
UH one of 4 sites participating in Phase II clinical trial - Innovations in Neurology & Neurosurgery | Winter 2020
Neurosurgeon advances brain cancer research, surgical techniques - Innovations in Neurology & Neurosurgery | Winter 2020
New $2.7 million grant from the National Cancer Institute will help validate promising approach - Innovations in Cancer | Summer 2019
Distinguishes tumor from healthy tissue to improve tumor removal The imaging agent 5-Aminolevulinic Acid (5-ALA), which helps neurosurgeons see the edges of a tumor more clearly to improve removal, was used in brain cancer surgery at University...
Andrew Sloan, MD, of University Hospitals Cleveland Medical Center, senior co-author of new report Andrew Sloan, MD, FACS A new study published in the Oct. 9 issue of the journal Nature Medicine demonstrates, for the first time, that...